These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 38098889)
1. Structural Dynamics of P-Rex1 Complexed with Natural Leads Establishes the Protein as an Attractive Target for Therapeutics to Suppress Cancer Metastasis. Hameed AR; Ali SF; Alsallameh SMS; Muhseen ZT; Almansour NM; ALSuhaymi N; Alsugoor MH; Allemailem KS Biomed Res Int; 2023; 2023():3882081. PubMed ID: 38098889 [TBL] [Abstract][Full Text] [Related]
2. Structural and Biochemical Characterization of the Catalytic Core of the Metastatic Factor P-Rex1 and Its Regulation by PtdIns(3,4,5)P3. Cash JN; Davis EM; Tesmer JJG Structure; 2016 May; 24(5):730-740. PubMed ID: 27150042 [TBL] [Abstract][Full Text] [Related]
3. Discovery of Small Molecules That Target the Phosphatidylinositol (3,4,5) Trisphosphate (PIP Cash JN; Chandan NR; Hsu AY; Sharma PV; Deng Q; Smrcka AV; Tesmer JJG Mol Pharmacol; 2020 Mar; 97(3):226-236. PubMed ID: 31900312 [TBL] [Abstract][Full Text] [Related]
4. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells. Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412 [TBL] [Abstract][Full Text] [Related]
5. Structural and dynamic changes in P-Rex1 upon activation by PIP Ravala SK; Adame-Garcia SR; Li S; Chen CL; Cianfrocco MA; Silvio Gutkind J; Cash JN; Tesmer JJG Elife; 2024 Jul; 12():. PubMed ID: 39082940 [TBL] [Abstract][Full Text] [Related]
6. Structural and dynamic changes in P-Rex1 upon activation by PIP Ravala SK; Adame-Garcia SR; Li S; Chen CL; Cianfrocco MA; Gutkind JS; Cash JN; Tesmer JJG bioRxiv; 2024 Apr; ():. PubMed ID: 37745379 [TBL] [Abstract][Full Text] [Related]
7. Upregulation of PIP3-dependent Rac exchanger 1 (P-Rex1) promotes prostate cancer metastasis. Qin J; Xie Y; Wang B; Hoshino M; Wolff DW; Zhao J; Scofield MA; Dowd FJ; Lin MF; Tu Y Oncogene; 2009 Apr; 28(16):1853-63. PubMed ID: 19305425 [TBL] [Abstract][Full Text] [Related]
8. Norbin Stimulates the Catalytic Activity and Plasma Membrane Localization of the Guanine-Nucleotide Exchange Factor P-Rex1. Pan D; Barber MA; Hornigold K; Baker MJ; Toth JM; Oxley D; Welch HC J Biol Chem; 2016 Mar; 291(12):6359-75. PubMed ID: 26792863 [TBL] [Abstract][Full Text] [Related]
9. Structural and biochemical characterization of the pleckstrin homology domain of the RhoGEF P-Rex2 and its regulation by PIP Cash JN; Sharma PV; Tesmer JJG J Struct Biol X; 2019; 1():100001. PubMed ID: 34958187 [TBL] [Abstract][Full Text] [Related]
10. The Rho guanine nucleotide exchange factor P-Rex1 as a potential drug target for cancer metastasis and inflammatory diseases. Ye RD Pharmacol Res; 2020 Mar; 153():104676. PubMed ID: 32006571 [TBL] [Abstract][Full Text] [Related]
11. The first DEP domain of the RhoGEF P-Rex1 autoinhibits activity and contributes to membrane binding. Ravala SK; Hopkins JB; Plescia CB; Allgood SR; Kane MA; Cash JN; Stahelin RV; Tesmer JJG J Biol Chem; 2020 Sep; 295(36):12635-12647. PubMed ID: 32661198 [TBL] [Abstract][Full Text] [Related]
12. The guanine-nucleotide-exchange factor P-Rex1 is activated by protein phosphatase 1α. Barber MA; Hendrickx A; Beullens M; Ceulemans H; Oxley D; Thelen S; Thelen M; Bollen M; Welch HC Biochem J; 2012 Apr; 443(1):173-83. PubMed ID: 22242915 [TBL] [Abstract][Full Text] [Related]
13. Gβγ signaling to the chemotactic effector P-REX1 and mammalian cell migration is directly regulated by Gα Cervantes-Villagrana RD; Adame-García SR; García-Jiménez I; Color-Aparicio VM; Beltrán-Navarro YM; König GM; Kostenis E; Reyes-Cruz G; Gutkind JS; Vázquez-Prado J J Biol Chem; 2019 Jan; 294(2):531-546. PubMed ID: 30446620 [TBL] [Abstract][Full Text] [Related]
14. Signaling requirements for translocation of P-Rex1, a key Rac2 exchange factor involved in chemoattractant-stimulated human neutrophil function. Zhao T; Nalbant P; Hoshino M; Dong X; Wu D; Bokoch GM J Leukoc Biol; 2007 Apr; 81(4):1127-36. PubMed ID: 17227822 [TBL] [Abstract][Full Text] [Related]
15. Cryo-electron microscopy structure and analysis of the P-Rex1-Gβγ signaling scaffold. Cash JN; Urata S; Li S; Ravala SK; Avramova LV; Shost MD; Gutkind JS; Tesmer JJG; Cianfrocco MA Sci Adv; 2019 Oct; 5(10):eaax8855. PubMed ID: 31663027 [TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of P-Rex1 by the cyclic AMP-dependent protein kinase inhibits the phosphatidylinositiol (3,4,5)-trisphosphate and Gbetagamma-mediated regulation of its activity. Mayeenuddin LH; Garrison JC J Biol Chem; 2006 Jan; 281(4):1921-8. PubMed ID: 16301320 [TBL] [Abstract][Full Text] [Related]
17. Virtual Screening for Potential Inhibitors of Human Hexokinase II for the Development of Anti-Dengue Therapeutics. Tanbin S; Ahmad Fuad FA; Abdul Hamid AA BioTech (Basel); 2020 Dec; 10(1):. PubMed ID: 35822774 [TBL] [Abstract][Full Text] [Related]
19. Systemic computational investigation to identify potential inhibitors against cancer by targeting P21-activated kinase 4 and D(CGATCG). Ahmed AH; Jassim TS; Ali RW; Hameed AR; Alfalki AM J Biomol Struct Dyn; 2023 Nov; 41(19):9356-9365. PubMed ID: 36326467 [TBL] [Abstract][Full Text] [Related]
20. A Comprehensive Computational Screening of Phytochemicals Derived from Saudi Medicinal Plants against Human CC Chemokine Receptor 7 to Identify Potential Anti-Cancer Therapeutics. Alrumaihi F Molecules; 2021 Oct; 26(21):. PubMed ID: 34770763 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]